直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
Emma N. Ng
Associate
More
vCard
  • 901 New York Avenue, NW
  • Washington, DC 20001-4413
+1 202 408 4149
emma.ng@finnegan.com emma.ng@finnegan.com

Emma N. Ng

Associate

  • +1 202 408 4149 +1 202 408 4149
  • emma.ng@finnegan.com emma.ng@finnegan.com
  • 901 New York Avenue, NW
  • Washington, DC 20001-4413
  • vCard

Emma Ng focuses on complex patent litigation and client counseling in areas related to biotechnical and pharmaceutical innovations. She represents clients before U.S. district courts and the U.S. Court of Appeals for the Federal Circuit, with a particular emphasis on litigating Abbreviated New Drug Application (ANDA) cases. 

Emma has extensive experience litigating high-stakes pharmaceutical cases, including matters involving billion-dollar and top-selling blockbuster drugs. Her work has provided her with deep insight into successful litigation strategies for innovator pharmaceutical companies.
 

Emma’s litigation practice spans federal district courts, appeals before the U.S. Court of Appeals for the Federal Circuit, and confidential arbitration proceedings. She is actively involved in all phases of litigation, from pre-litigation counseling and case strategy development to fact and expert discovery as well as claim construction. Her primary focus is on ANDA litigation and disputes involving medical device innovations and trade secrets. Emma’s work has contributed to favorable outcomes for clients, including successful settlements.
 

Emma is committed to pro bono service and has been recognized multiple times on the Capital Pro Bono High Honor Roll for her representation of asylum seekers, including securing a grant of asylum for a client. She has also successfully represented veterans before the U.S. Court of Appeals for Veterans Claims and the Naval Discharge Review Board and has volunteered with the Election Protection Hotline.
 

During law school, Emma gained international legal experience as a Milt Stewart Fellow in China, where she assisted with client counseling, global trademark portfolio protection, and trademark enforcement.

 

Et Cetera

  • Member, Planning Committee, Finnegan's Together We Soar Summit, 2024-2025.

  • Co-author. Lasting Impact: Why You Should Care About Court of Customs and Patent Appeal Cases, AIPLA Quarterly Journal, 51, 39, 2023.

  • Audio editor, Indiana University IP Theory Law Journal, 2020-2021.

  • Participant, AIPLA Giles Sutherland Rich Moot Court Competition, 2021.

  • Student volunteer, Indiana University Intellectual Property Law Clinic, 2020.

  • Dean's Writing Fellow, 2019-2020.

  • Participant, Sherman Minton Moot Court, Oral Advocacy Honors, 2018.

     

Experience

Incyte Corporation et al. v. Sun Pharmaceutical Industries Limited et al.

Successfully represented Incyte in patent litigation, including preliminary injunction proceedings related to Sun Pharmaceuticals’ deuterated Janus kinase (JAK) inhibitor, LEQSELVI™. Case settled favorably for our client.

2:24-cv-06944, D.N.J., Judge Padin

AbbVie Inc., et al. v. Aurobindo Pharma U.S.A., Inc. et al.

Finnegan is representing AbbVie, Allergan, and Merck in ongoing ANDA litigation involving Ubrelvy®, indicated for the acute treatment of migraine with or without aura in adults.

3:24-cv-04603, D.N.J., Judges Quraishi, Day
3:24-cv-04662, D.N.J., Judges Quraishi, Day
3:24-cv-04852, D.N.J., Judges Quraishi, Day

Insights

Articles

Unpacking the PTAB’s Patent Age Denial Doctrine Data

Unpacking the PTAB’s Patent Age Denial Doctrine Data Unpacking the PTAB’s Patent Age Denial Doctrine Data

August 29, 2025

Intellectual Asset Management (IAM)

Articles

Trending at the PTAB: IPR Memo and Its Fed. Circ. Backdrop

Trending at the PTAB: IPR Memo and Its Fed. Circ. Backdrop Trending at the PTAB: IPR Memo and Its Fed. Circ. Backdrop

August 22, 2025

Law360

Federal Circuit IP Blog

Don’t Sleep on This: Federal Circuit Reverses Permanent Injunction Barring Clinical Trials and New Indications for NDA Don’t Sleep on This: Federal Circuit Reverses Permanent Injunction Barring Clinical Trials and New Indications for NDA

May 20, 2025

Federal Circuit IP Blog

Federal Circuit Affirms Principle of Party Presentation Allows the Parties, Not the Court, to Chart the Course of a Litigation Federal Circuit Affirms Principle of Party Presentation Allows the Parties, Not the Court, to Chart the Course of a Litigation

October 9, 2024

At the PTAB Blog

Board’s Failure to Meet Statutory Deadline to Issue Final Written Decision Does Not Result in Loss of Board’s Jurisdiction Board’s Failure to Meet Statutory Deadline to Issue Final Written Decision Does Not Result in Loss of Board’s Jurisdiction

July 16, 2024

Federal Circuit IP Blog

PTAB’s Implicit Claim Construction in Obviousness Analysis Constitutes Claim Construction, Even When Its Decision States It Did Not Construe Claims PTAB’s Implicit Claim Construction in Obviousness Analysis Constitutes Claim Construction, Even When Its Decision States It Did Not Construe Claims

March 21, 2024

More

News

Award/Ranking

61 Finnegan Attorneys Recognized on the 2025 Capital Pro Bono Honor Roll 61 Finnegan Attorneys Recognized on the 2025 Capital Pro Bono Honor Roll

May 7, 2026

Award/Ranking

Finnegan Associates Honored with Young Lawyer of the Year Award

Finnegan Associates Honored with Young Lawyer of the Year Award

December 7, 2025

Award/Ranking

56 Finnegan Attorneys Recognized on the 2024 Capital Pro Bono Honor Roll 56 Finnegan Attorneys Recognized on the 2024 Capital Pro Bono Honor Roll

April 24, 2025

DC Bar

Award/Ranking

60 Finnegan Attorneys Named to 2023 Capital Pro Bono Honor Roll

60 Finnegan Attorneys Named to 2023 Capital Pro Bono Honor Roll

May 15, 2024

Award/Ranking

54 Finnegan Attorneys Named to 2022 Capital Pro Bono Honor Roll 54 Finnegan Attorneys Named to 2022 Capital Pro Bono Honor Roll

July 21, 2023

Professional Activities

  • American Intellectual Property Law Association (AIPLA)
  • Asian Pacific American Bar Association (APABA)
Admissions and Education

Admissions

  • U.S. Patent and Trademark Office
  • District of Columbia
  • U.S. Court of Appeals, Federal Circuit
  • U.S. Court of Appeals, Veterans Claims

Education

Indiana University Maurer School of Law
J.D., 2021
Indiana University Bloomington
B.A., Human Biology, 2017

Emma's Practices

Global IP Enforcement, Litigation, and Trials
Branded Hatch-Waxman (ANDA) Litigation and Trials
Federal Circuit and Supreme Court Appeals
Patent Litigation and Trials
Prosecution and Portfolio Management
Patent Drafting and Prosecution

Emma's Industries

Chemicals, Industrials, and Materials
Chemical
Textiles
Consumer Goods and Services
Consumer Products
Food and Beverage
Energy
Clean Energy and Renewables
Life Sciences
Biologics
Biotechnology
Digital Health
Medical Device and Diagnostics
Pharmaceutical

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP